Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged-Release Fampridine in Japanese Subjects With Multiple Sclerosis
NCT01917019Phase 3Completed
- Sponsor
- Biogen
- Start
- Aug 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fampridine in multiple sclerosis (MS), sponsored by Biogen. Started Aug 2013; status: completed.
02
Drugs
fampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01917019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917019.